American Healthcare REIT (AHR) just shifted into larger cap territory after being added to the Russell 1000 and several related value and defensive indexes, while exiting multiple Russell 2000 and growth benchmarks.

At a latest share price of $51.00, American Healthcare REIT has seen momentum pick up recently, with a 7-day share price return of 8.14% and a year to date share price return of 7.96%. The 1-year total shareholder return of 41.14% points to stronger gains over a longer holding period as the index additions and recent earnings optimism have come into focus.

If you are interested in how other healthcare focused companies are being repriced, it could be a useful time to scan 40 healthcare AI stocks.

With American Healthcare REIT now included in larger cap, value and defensive indexes, a higher analyst price target in place, and recent earnings optimism, the central question is whether AHR still trades below fair value or whether markets are already pricing in future growth.

Most Popular Narrative: 13.3% Undervalued

Compared with the most followed fair value estimate of $58.85, American Healthcare REIT at $51.00 screens as meaningfully cheaper. This is what makes the underlying growth story and cash flow assumptions so important.

The combination of a rapidly growing 80+ demographic and a multi-year period of low new supply in senior housing and skilled nursing is expected to drive a persistent supply-demand imbalance, fueling both occupancy gains and rent growth across American Healthcare REIT's portfolio; this dynamic should underpin above-trend revenue and net operating income growth over the next decade.

Read the complete narrative. Read the complete narrative.

Want to see what kind of revenue trajectory and margin uplift sits behind that fair value, and how it links to a richer earnings profile? The key ingredients include faster top line expansion, a step up in profitability, and a future earnings multiple that implies investors are willing to pay up for that story. Curious how those pieces fit together, year by year, to back a higher valuation than today?

Analysts supplying this narrative are building their $58.85 fair value on compounding revenue growth, improving net profit margins and a future P/E that remains above the health care REIT peer group. Those inputs are all discounted at 7.24%, so the outcome reflects the view that projected cash flows justify a higher price than the current $51.00, even after accounting for risk and the time value of money.

Result: Fair Value of $58.85 (UNDERVALUED)

However, the American Healthcare REIT story also depends on maintaining high occupancy and healthy rate growth in senior housing, while managing reimbursement and outpatient medical headwinds.

Another View: American Healthcare REIT Looks Expensive On Earnings

That 13.3% discount to a $58.85 fair value points to upside for American Healthcare REIT, but the P/E ratio of about 98x tells a different story. It sits well above the global Health Care REITs industry at 20.2x and the 46.3x fair ratio that our work suggests the market could move toward. That gap points to real valuation risk if sentiment cools or growth assumptions are revised.

For a closer look at what this earnings multiple might imply for future returns versus peers, check the valuation breakdown in the See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Seeing mixed signals around American Healthcare REIT's valuation and growth story? Use the data, weigh both sides, and move quickly to review the 3 key rewards and 2 important warning signs

Looking for more investment ideas beyond American Healthcare REIT?

If you are serious about building a stronger portfolio, do not stop with American Healthcare REIT. Use the Simply Wall Street Screener to broaden your opportunity set.

• Target potential upside by scanning 44 high quality undervalued stocks that pair appealing pricing with fundamentals investors are watching closely.
• Strengthen your income stream by reviewing 8 dividend fortresses that focus on higher yields with an eye on durability.
• Dial back portfolio risk by assessing 69 resilient stocks with low risk scores that may offer more resilient return profiles through different market conditions.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.